KEYTRUDA® approved by the FDA twice in one week

KEYTRUDA® approved by the FDA twice in one week

Last week was quite busy for Merck (MSD outside the US and Canada) with its immunotherapy Keytruda® (pembrolizumab) obtaining not only one, but two FDA approvals.

Read more

Previous

Next